Simplicity Wealth LLC Buys New Position in Waldencast plc (NASDAQ:WALD)

Simplicity Wealth LLC bought a new stake in Waldencast plc (NASDAQ:WALD) during the first quarter, HoldingsChannel.com reports. The fund bought 21,853 shares of the company’s stock, valued at approximately $142,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Barclays PLC raised its position in Waldencast by 75.3% in the 3rd quarter. Barclays PLC now owns 7,177 shares of the company’s stock valued at $67,000 after buying an additional 3,084 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Waldencast by 23.2% during the 4th quarter. SG Americas Securities LLC now owns 19,705 shares of the company’s stock worth $216,000 after purchasing an additional 3,716 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Waldencast by 44.4% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,226 shares of the company’s stock worth $178,000 after purchasing an additional 4,992 shares during the last quarter. State Board of Administration of Florida Retirement System acquired a new position in shares of Waldencast during the 3rd quarter worth approximately $97,000. Finally, Bank of New York Mellon Corp increased its position in shares of Waldencast by 73.6% during the 3rd quarter. Bank of New York Mellon Corp now owns 86,409 shares of the company’s stock worth $814,000 after purchasing an additional 36,642 shares during the last quarter. Institutional investors and hedge funds own 41.97% of the company’s stock.

Waldencast Price Performance

Shares of Waldencast stock traded up $0.11 during trading on Friday, reaching $4.18. 116,382 shares of the company’s stock were exchanged, compared to its average volume of 110,634. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.71 and a quick ratio of 0.82. Waldencast plc has a 1-year low of $3.71 and a 1-year high of $12.00. The firm’s 50-day moving average price is $5.58 and its 200 day moving average price is $7.64.

Analysts Set New Price Targets

Separately, Telsey Advisory Group restated an “outperform” rating and issued a $8.00 price target on shares of Waldencast in a research note on Tuesday.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.